Summary of Significant Accounting Policies - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Carrying Value, Total	$ 42,618,457	$ 7,034,915
Fair Value, Total	42,618,457	7,034,915
Derivative Liabilities [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Carrying Value, Total	35,450,735	2
Fair Value, Total	35,450,735	2
Investment in Evofem Warrants [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Carrying Value, Total	3,160,058	3,135,054
Fair Value, Total	3,160,058	3,135,054
Evofem Note [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Carrying Value, Total	4,007,664	3,899,859
Fair Value, Total	4,007,664	3,899,859
Level 1 [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 1 [Member] \| Derivative Liabilities [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 1 [Member] \| Investment in Evofem Warrants [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 1 [Member] \| Evofem Note [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 2 [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total	38,610,793	3,135,056
Level 2 [Member] \| Derivative Liabilities [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total	35,450,735	2
Level 2 [Member] \| Investment in Evofem Warrants [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total	3,160,058	3,135,054
Level 2 [Member] \| Evofem Note [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 3 [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total	4,007,664	3,899,859
Level 3 [Member] \| Derivative Liabilities [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 3 [Member] \| Investment in Evofem Warrants [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total
Level 3 [Member] \| Evofem Note [Member]
Schedule of Financial Instruments Measured at Fair Value [Line Items]
Fair Value, Total	$ 4,007,664	$ 3,899,859